Фибрилляция предсердий после операций аортокоронарного шунтирования: факторы риска, профилактика и лечение

В настоящем обзоре литературы рассматривается проблема развития фибрилляции предсердий (ФП) после операций аортокоронарного шунтирования у пациентов с ишемической болезнью сердца. Подробно освещаются факторы риска развития данного осложнения. Обсуждаются результаты исследований о влиянии сахарног диабета на развитие послеоперационной ФП. Приводятся данные о современных методах профилактики и лечения ФП.

1. Федеральная служба государственной статистики. Здравоохранение в России. 2019. Статистический сборник. - М.: Росстат, 2019. - 170с. Доступно на: https://www.gks.ru/storage/mediabank/Zdravoohran-2019.pdf. ISBN 978-5-89476-470-2

2. Фисенко В.С., Рогинко Н.И., Корочкин А.В. Выполнение основных целевых показателей по снижению смертности от болезней системы кровообращения в субъектах Российской Федерации (по результатам контрольно-надзорных мероприятий Росздравнадзора). Вестник Росздравнадзора. 2015;5:26-32

3. Акчурин Р.С., Ширяев А.А., Власова Э.Е., Васильев В.П., Галяутдинов Д.М. Хирургическое лечение ишемической болезни сердца. Русский Медицинский Журнал. 2014;22(30):2152-7

4. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. Heart Disease and Stroke Statistics–2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–360. DOI: 10.1161/CIR.0000000000000350

5. Favaloro RG. Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion. The Annals of Thoracic Surgery. 1968;5(4):334–9. DOI: 10.1016/S0003-4975(10)66351-5

6. Бокерия Л.А., Авалиани В.М., Мерзляков В.Ю. Аортокоронарное шунтирование на работающем сердце. - М.: НЦССХ им. А.Н. Бакулева РАМН, 2008. – 490c. ISBN 978-5-7982-0227-0

7. Osnabrugge RL, Kappetein AP, Head SJ, Kolh P. Doing better in more complex patients: leading the way for QUIP. European Journal of Cardio-Thoracic Surgery. 2016;49(2):397–8. DOI: 10.1093/ejcts/ezv262

8. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394

9. Weedle RC, Costa MD, Veerasingam D, Soo AWS. The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. Annals of Translational Medicine. 2019;7(23):778– 778. DOI: 10.21037/atm.2019.11.17

10. Зафираки В.К., Скалецкий К.В., Ставенчук Т.В., Космачева Е.Д. Периоперационные осложнения аортокоронарного шунтирования при сочетании стабильной стенокардии напряжения и хронической обструктивной болезни легких. Кубанский научный медицинский вестник. 2014;3(145):49-53

11. Thorén E, Hellgren L, Ståhle E. High incidence of atrial fibrillation after coronary surgery. Interactive CardioVascular and Thoracic Surgery. 2016;22(2):176–80. DOI: 10.1093/icvts/ivv326

12. Filardo G, Damiano RJ, Ailawadi G, Thourani VH, Pollock BD, Sass DM et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 2018;104(12):985–92. DOI: 10.1136/heartjnl-2017-312150

13. Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. European Journal of Cardio-Thoracic Surgery. 2017;52(4):665–72. DOI: 10.1093/ejcts/ezx039

14. Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. New England Journal of Medicine. 2016;374(20):1911–21. DOI: 10.1056/NEJMoa1602002

15. Бокерия Л.А., Голухова Е.З., Алшибая М.Д., Какучая Т.Т. Прогнозирование развития фибрилляции предсердий после операций аортокоронарного шунтирования. Анналы аритмологии. 2004;1(1):77-86

16. Melby SJ, George JF, Picone DJ, Wallace JP, Davies JE, George DJ et al. A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. The Journal of Thoracic and Cardiovascular Surgery. 2015;149(3):886–92. DOI: 10.1016/j.jtcvs.2014.11.032

17. Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery. Journal of the American College of Cardiology. 2008;51(8):793–801. DOI: 10.1016/j.jacc.2007.10.043

18. Auer J, Weber T, Berent R, Ng C-K, Lamm G, Eber B. Risk Factors of Postoperative Atrial Fibrillation After Cardiac Surgery. Journal of Cardiac Surgery. 2005;20(5):425–31. DOI: 10.1111/j.1540-8191.2005.2004123.x

19. Бокерия Л.А., Бокерия О.Л., Гафуров Ф.С. Современное состояние проблемы профилактики фибрилляции предсердий в раннем периоде после операций аортокоронарного шунтирования. Новости хирургии. 2018;26(5):605-15. DOI: 10.18484/2305-0047.2018.5.605

20. Hernández-Leiva E, Alvarado P, Dennis RJ. Postoperative Atrial Fibrillation: Evaluation of its Economic Impact on the Costs of Cardiac Surgery. Brazilian Journal of Cardiovascular Surgery. 2019;34(2):179–86. DOI: 10.21470/1678-9741-2018-0218

21. Megens MR, Churilov L, Thijs V. New‐Onset Atrial Fibrillation After Coronary Artery Bypass Graft and Long‐Term Risk of Stroke: A Meta‐Analysis. Journal of the American Heart Association. 2017;6(12):e007558. DOI: 10.1161/JAHA.117.007558

22. Burrage PS, Low YH, Campbell NG, O’Brien B. New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery. Current Anesthesiology Reports. 2019;9(2):174–93. DOI: 10.1007/s40140-019-00321-4

23. Ломиворотов В.В., Ефремов С.М., Покушалов Е.А., Бобошко В.А. Фибрилляция предсердий после кардиохирургических операций: патофизиология и методы профилактики. Вестник анестезиологии и реаниматологии. 2017;14(1):58-66. DOI: 10.21292/2078-5658-2017-14-1-58-66

24. Folla C de O, Melo CC de S, Silva R de CG e, Universidade de São Paulo, Brazil, Universidade de São Paulo, Brazil. Predictive factors of atrial fibrillation after coronary artery bypass grafting. Einstein (São Paulo). 2016;14(4):480–5. DOI: 10.1590/s1679-45082016ao3673

25. Меликулов А.Х., Маглакелидзе Д.А. Возможные механизмы и стратегии профилактики фибрилляции предсердий после операций на открытом сердце. Анналы аритмологии. 2012;9(1):13-9

26. Mathew JP. A Multicenter Risk Index for Atrial Fibrillation After Cardiac Surgery. JAMA. 2004;291(14):1720–9. DOI: 10.1001/jama.291.14.1720

27. Ommen SR, Odell JA, Stanton MS. Atrial Arrhythmias after Cardiothoracic Surgery. New England Journal of Medicine. 1997;336(20):1429–34. DOI: 10.1056/NEJM199705153362006

28. Cerit L, Kemal H, Gulsen K, Ozcem B, Cerit Z, Duygu H. Relationship between Vitamin D and the development of atrial fibrillation after on-pump coronary artery bypass graft surgery. Cardiovascular Journal of Africa. 2017;28(2):104–7. DOI: 10.5830/CVJA-2016-064

29. Ferreira AF, Saraiva FA, Cerqueira RJ, Moreira R, Amorim MJ, Pinho P et al. P1243Postoperative atrial fibrillation after coronary artery bypass grafting surgery. European Heart Journal. 2018;39(Suppl 1):245. DOI: 10.1093/eurheartj/ehy565.P1243

30. Goette A, Juenemann G, Peters B, Klein H, Roessner A, Huth C et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovascular Research. 2002;54(2):390–6. DOI: 10.1016/S0008-6363(02)00251-1

31. Jannati M. Atrial Fibrillation Post Coronary Artery Graft Surgery: A Review Of Literature. International Journal of General Medicine. 2019;12:415–20. DOI: 10.2147/IJGM.S227761

32. Avdic S, Osmanovic E, Kadric N, Mujanovic E, Ibisevic M, Avdici and. Time of Occurrence and Duration of Atrial Fibrillation Following Coronary Artery Bypass Grafting. Medical Archives. 2016;70(2):97–100. DOI: 10.5455/medarh.2016.70.97-100

33. Wang W-H, Hsiao S-H, Lin K-L, Wu C-J, Kang P-L, Chiou K-R. Left Atrial Expansion Index for Predicting Atrial Fibrillation and In-Hospital Mortality After Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery. 2012;93(3):796–803. DOI: 10.1016/j.athoracsur.2011.11.007

34. Zhou A-G, Wang X-X, Pan D-B, Chen A, Zhang X, Deng H. Preoperative Antihypertensive Medication in Relation to Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis. BioMed Research International. 2017;2017:1– 12. DOI: 10.1155/2017/1203538

35. Peretto G, Durante A, Limite LR, Cianflone D. Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management. Cardiology Research and Practice. 2014;2014:615987. DOI: 10.1155/2014/615987

36. Байракова Ю.В., Иванов С.В., Казачек Я.В., Баздырев Е.Д., Малышенко Е.С., Кургузова Е.М. и др. Факторы риска развития суправентрикулярных нарушений ритма в госпитальном периоде после коронарного шунтирования. Сибирский Медицинский Журнал (Иркутск). 2011;104(5):44-7

37. Dublin S. Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index. Archives of Internal Medicine. 2006;166(21):2322. DOI: 10.1001/archinte.166.21.2322

38. Echahidi N, Mohty D, Pibarot P, Despres J-P, O’Hara G, Champagne J et al. Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Circulation. 2007;116(11 Suppl):I213-219. DOI: 10.1161/CIRCULATIONAHA.106.681304

39. Sim MA, Liu W, Chew STH, Ti LK. Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay. PLOS ONE. 2018;13(6):e0198533. DOI: 10.1371/journal.pone.0198533

40. Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 2011;41(1):102–7. DOI: 10.1016/j.ejcts.2011.04.011

41. Колесников В.Н., Боева О.И., Иваненко А.С., Ягода А.В. Прогнозирование фибрилляции предсердий после хирургической реваскуляризации миокарда: проспективное сравнительное исследование. Медицинский вестник Северного Кавказа. 2014;9(4):320-5. DOI: 10.14300/mnnc.2014.09090

42. Saskin H, Duzyol Ç, Aksoy R, Ozcan KS, Güngö B, İdiz M. Do preoperative C-reactive protein and mean platelet volume levels predict development of postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting? Advances in Interventional Cardiology. 2016;12(2):156–63. DOI: 10.5114/aic.2016.59366

43. Demir M, Uyan U, Melek M. The Effects of Vitamin D Deficiency on Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis. 2014;20(1):98–103. DOI: 10.1177/1076029612453762

44. Zhang Z, Yang Y, Ng CY, Wang D, Wang J, Li G et al. Metaanalysis of Vitamin D Deficiency and Risk of Atrial Fibrillation: Vitamin D deficiency and risk of AF. Clinical Cardiology. 2016;39(9):537–43. DOI: 10.1002/clc.22563

45. Ozsin KK, Sanrı US, Toktaş F, Kahraman N, Yavuz Ş. Effect of Plasma Level of Vitamin D on Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Brazilian Journal of Cardiovascular Surgery. 2018;33(3):217–23. DOI: 10.21470/1678-9741-2017-0214

46. Puskas JD, Edwards FH, Pappas PA, O’Brien S, Peterson ED, Kilgo P et al. Off-Pump Techniques Benefit Men and Women and Narrow the Disparity in Mortality After Coronary Bypass Grafting. The Annals of Thoracic Surgery. 2007;84(5):1447–56. DOI: 10.1016/j.athoracsur.2007.06.104

47. Williams JB, Peterson ED, Wojdyla D, Harskamp R, Southerland KW, Ferguson TB et al. Central venous pressure after coronary artery bypass surgery: Does it predict postoperative mortality or renal failure? Journal of Critical Care. 2014;29(6):1006–10. DOI: 10.1016/j.jcrc.2014.05.027

48. Costa MAC da, Lirani W, Wippich AC, Lopes L, Tolentino E de S, Zampar B et al. Comparison of Two Central Venous Pressure Control Strategies to Prevent Atrial Fibrillation After Coronary Artery Bypass Grafting. Arquivos Brasileiros de Cardiologia. 2017;108(4):297–303. DOI: 10.5935/abc.20170044

49. Базылев В.В., Немченко Е.В., Сластин Я.С., Карнахин В.А., Павлов А.А. Взаимосвязь SYNTAX score и фибрилляции предсердий в раннем послеоперационном периоде у пациентов после изолированного коронарного шунтирования. CardioСоматика. 2018;8(1):5-9. DOI: 10.26442/2221-7185_2018.1.5-9

50. Todorov H, Janssen I, Honndorf S, Bause D, Gottschalk A, Baasner S et al. Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery – a retrospective data analysis. BMC Anesthesiology. 2017;17(1):163–73. DOI: 10.1186/s12871-017-0455-7

51. Yadava M, Hughey AB, Crawford TC. Postoperative Atrial Fibrillation: incidence, mechanisms, and clinical correlates. Heart Failure Clinics. 2016;12(2):299–308. DOI: 10.1016/j.hfc.2015.08.023

52. Kramer PA, Chacko BK, Ravi S, Johnson MS, Mitchell T, Barnes S et al. Hemoglobin-associated oxidative stress in the pericardial compartment of postoperative cardiac surgery patients. Laboratory Investigation. 2015;95(2):132–41. DOI: 10.1038/labinvest.2014.144

53. Anselmi A, Possati G, Gaudino M. Postoperative Inflammatory Reaction and Atrial Fibrillation: Simple Correlation or Causation? The Annals of Thoracic Surgery. 2009;88(1):326–33. DOI: 10.1016/j.athoracsur.2009.01.031

54. D’Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. The Annals of Thoracic Surgery. 2018;105(1):15–23. DOI: 10.1016/j.athoracsur.2017.10.035

55. Акчурин Р.С., Власова Э.Е., Мершин К.В. Сахарный диабет и хирургическое лечение ишемической болезни сердца. Вестник Российской Академии Медицинских Наук. 2012;67(1):14-9

56. World Health Organization. Global report on diabetes. –Geneva: WHO;2018. - 88 p. ISBN 978-92-4-456525-4

57. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2020;41(2):255–323. DOI: 10.1093/eurheartj/ehz486

58. Bundhun PK, Wu ZJ, Chen M-H. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovascular Diabetology. 2016;15(1):2. DOI: 10.1186/s12933-015-0323-z

59. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary Artery Bypass Graft Surgery vs Percutaneous Interventions in Coronary Revascularization: A Systematic Review. JAMA. 2013;310(19):2086–95. DOI: 10.1001/jama.2013.281718

60. Renner A, Zittermann A, Aboud A, Pühler T, Hakim-Meibodi K, Quester W et al. Coronary Revascularization in Diabetic Patients: Off-Pump Versus On-Pump Surgery. The Annals of Thoracic Surgery. 2013;96(2):528–34. DOI: 10.1016/j.athoracsur.2013.04.063

61. Raza S, Sabik JF, Masabni K, Ainkaran P, Lytle BW, Blackstone EH. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(4):1257-1266. e9. DOI: 10.1016/j.jtcvs.2014.06.058

62. Tatsuishi W, Adachi H, Murata M, Tomono J, Okonogi S, Okada S et al. Postoperative Hyperglycemia and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Circulation Journal. 2014;79(1):112–8. DOI: 10.1253/circj.CJ-14-0989

63. Sato H, Hosojima M, Ishikawa T, Aoki K, Okamoto T, Saito A et al. Glucose Variability Based on Continuous Glucose Monitoring Assessment Is Associated with Postoperative Complications after Cardiovascular Surgery. Annals of Thoracic and Cardiovascular Surgery. 2017;23(5):239–47. DOI: 10.5761/atcs.oa.17-00045

64. Безденежных Н.А., Сумин А.Н., Барбараш О.Л. Пациент с сахарным диабетом и реваскуляризация миокарда с позиций доказательной медицины: взгляд кардиолога. Часть 1. Российский кардиологический журнал. 2017;22(4):105-13. DOI: 10.15829/1560-4071-2017- 4-105-113

65. Сумин А.Н., Безденежных Н.А., Безденежных А.В., Осокина А.В., Кузьмина А.А., Груздева О.В. и др. Предоперационный статус и госпитальные осложнения коронарного шунтирования у пациентов с предиабетом и сахарным диабетом 2 типа. Российский кардиологический журнал. 2018;23(5):40-8. DOI: 10.15829/1560-4071-2018-5-40-48

66. Ujueta F, Weiss EN, Sedlis SP, Shah B. Glycemic Control in Coronary Revascularization. Current Treatment Options in Cardiovascular Medicine. 2016;18(2):12. DOI: 10.1007/s11936-015-0434-6

67. Gatti G, Dell’Angela L, Maschietto L, Luzzati R, Sinagra G, Pappalardo A. The Impact of Diabetes on Early Outcomes after Routine Bilateral Internal Thoracic Artery Grafting. Heart, Lung and Circulation. 2016;25(8):862–9. DOI: 10.1016/j.hlc.2016.02.009

68. Сумин А.Н., Безденежных Н.А., Иванов С.В., Барбараш О.Л., Барбараш Л.С. К вопросу о риске послеоперационных осложнений коронарного шунтирования у пациентов с СД II типа. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2012;13(5):59-68

69. Сумин А.Н., Безденежных Н.А., Безденежных А.В., Иванов С.В., Барбараш О.Л. Факторы риска больших сердечно-сосудистых событий в отдаленном периоде коронарного шунтирования у пациентов с ишемической болезнью сердца при наличии сахарного диабета 2 типа. Российский кардиологический журнал. 2015;20(6):30-7

70. Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J et al. Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American Journal of Cardiology. 2014;114(8):1217–22. DOI: 10.1016/j.amjcard.2014.07.045

71. Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression. PLOS ONE. 2017;12(3):e0170955. DOI: 10.1371/journal.pone.0170955

72. Surer S, Seren M, Saydam O, Bulut A, Kiziltepe U. The Relationship between HbA1c and Atrial fibrillation After Off-pump Coronary Artery Bypass Surgery in Diabetic Patients. Pakistan Journal of Medical Sciences. 2016;32(1):59–64. DOI: 10.12669/pjms.321.8588

73. Subramaniam B, Lerner A, Novack V, Khabbaz K, Paryente-Wiesmann M, Hess P et al. Increased Glycemic Variability in Patients with Elevated Preoperative HbA1c Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery. Anesthesia & Analgesia. 2014;118(2):277–87. DOI: 10.1213/ANE.0000000000000100

74. Alawami M, Chatfield A, Ghashi R, Walker L. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. Journal of the Saudi Heart Association. 2018;30(1):40–6. DOI: 10.1016/j.jsha.2017.03.008

75. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. DOI: 10.1093/europace/euw295

76. Thein PM, White K, Banker K, Lunny C, Mirzaee S, Nasis A. Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis. Heart, Lung and Circulation. 2018;27(3):310–21. DOI: 10.1016/j.hlc.2017.08.026

77. Turagam MK, Downey FX, Kress DC, Sra J, Tajik AJ, Jahangir A. Pharmacological strategies for prevention of postoperative atrial fibrillation. Expert Review of Clinical Pharmacology. 2015;8(2):233–50. DOI: 10.1586/17512433.2015.1018182

78. Wang H-S, Wang Z-W, Yin Z-T. Carvedilol for Prevention of Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis. PLoS ONE. 2014;9(4):e94005. DOI: 10.1371/journal.pone.0094005

79. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. European Heart Journal. 2006;27(23):2846–57. DOI: 10.1093/eurheartj/ehl272

80. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery. New England Journal of Medicine. 2005;353(4):349–61. DOI: 10.1056/NEJMoa041895

81. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. The Lancet. 2008;371(9627):1839–47. DOI: 10.1016/S0140-6736(08)60601-7

82. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24):2215–45. DOI: 10.1161/CIR.0000000000000105

83. Kerin NZ, Jacob S. The Efficacy of Sotalol in Preventing Postoperative Atrial Fibrillation: A Meta-Analysis. The American Journal of Medicine. 2011;124(9):875.e1-875.e9. DOI: 10.1016/j.amjmed.2011.04.025

84. Somberg J, Molnar J. Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. Journal of Atrial Fibrillation. 2016;8(5):1359. DOI: 10.4022/jafib.1359

85. Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19(2):190– 225. DOI: 10.1093/europace/euw242

86. Balik M, Sander M, Trimmel H, Heinz G. Landiolol for managing post-operative atrial fibrillation. European Heart Journal Supplements. 2018;20(Suppl A):A10–4. DOI: 10.1093/eurheartj/sux036

87. Fellahi J-L, Heringlake M, Knotzer J, Fornier W, Cazenave L, Guarracino F. Landiolol for managing atrial fibrillation in post-cardiac surgery. European Heart Journal Supplements. 2018;20(Suppl A):A4–9. DOI: 10.1093/eurheartj/sux038

88. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(3):e153–93. DOI: 10.1016/j.jtcvs.2014.06.036

89. Muehlschlegel JD, Burrage PS, Ngai JY, Prutkin JM, Huang C-C, Xu X et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. Anesthesia & Analgesia. 2019;128(1):33–42. DOI: 10.1213/ANE.0000000000003865

90. Mehaffey JH, Hawkins RB, Byler M, Smith J, Kern JA, Kron I et al. Amiodarone Protocol Provides Cost-Effective Reduction in Postoperative Atrial Fibrillation. The Annals of Thoracic Surgery. 2018;105(6):1697–702. DOI: 10.1016/j.athoracsur.2017.12.029

91. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial. JAMA. 2005;294(24):3093. DOI: 10.1001/jama.294.24.3093

92. Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta-analysis. Pacing and Clinical Electrophysiology. 2013;36(8):1017–23. DOI: 10.1111/pace.12140

93. Onk OA, Erkut B. Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery? Medicine. 2015;94(41):e1576. DOI: 10.1097/MD.0000000000001576

94. Alqahtani AwadAR. Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010;11(2):57–63. DOI: 10.4103/1995-705X.73212

95. Zheng H, Xue S, Hu Z-L, Shan J-G, Yang W-G. The Use of Statins to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Meta-analysis of 12 Studies. Journal of Cardiovascular Pharmacology. 2014;64(3):285–92. DOI: 10.1097/FJC.0000000000000102

96. Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. Journal of Cardiovascular Pharmacology and Therapeutics. 2016;21(2):167–76. DOI: 10.1177/1074248415602557

97. Бокерия О.Л., Ахобеков А.А., Шварц В.А., Кудзоева З.Ф. Эффективность приема статинов в первичной профилактике фибрилляции предсердий в раннем послеоперационном периоде изолированного аортокоронарного шунтирования. Вестник Российской Академии Медицинских Наук. 2015;70(3):273-8. DOI: 10.15690/vramn.v70i3.1322

98. Chopra V, Wesorick DH, Sussman JB, Greene T, Rogers M, Froehlich JB et al. Effect of Perioperative Statins on Death, Myocardial Infarction, Atrial Fibrillation, and Length of Stay: A Systematic Review and Meta-analysis. Archives of Surgery. 2012;147(2):181–9. DOI: 10.1001/archsurg.2011.897

99. Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study. Circulation. 2006;114(14):1455–61. DOI: 10.1161/CIRCULATIONAHA.106.621763

100. Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database of Systematic Reviews. 2013;7:CD009971. DOI: 10.1002/14651858.CD009971.pub2

101. Putzu A, Capelli B, Belletti A, Cassina T, Ferrari E, Gallo M et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Critical Care. 2016;20(1):395. DOI: 10.1186/s13054-016-1560-6

102. Ishii Y, Schuessler RB, Gaynor SL, Hames K, Damiano RJ. Postoperative atrial fibrillation: The role of the inflammatory response. The Journal of Thoracic and Cardiovascular Surgery. 2017;153(6):1357–65. DOI: 10.1016/j.jtcvs.2016.12.051

103. Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman CI. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007;4(4):461–8. DOI: 10.1016/j.hrthm.2006.11.026

104. Dieleman JM. Intraoperative High-Dose Dexamethasone for Cardiac Surgery: A Randomized Controlled Trial. JAMA. 2012;308(17):1761–7. DOI: 10.1001/jama.2012.14144

105. Dvirnik N, Belley-Cote EP, Hanif H, Devereaux PJ, Lamy A, Dieleman JM et al. Steroids in cardiac surgery: a systematic review and meta-analysis. British Journal of Anaesthesia. 2018;120(4):657–67. DOI: 10.1016/j.bja.2017.10.025

106. Боева О.И., Колесников В.Н., Иваненко А.С., Краснов А.Ю., Булгакова Н.Е., Щеглова Е.В. Новые возможности профилактики послеоперационной фибрилляции предсердий. Современные проблемы науки и образования. 2015;5:134. DOI: 10.17513/spno.128-21966

107. Панов А.В., Татарский Б.А., Гордеев М.Л., Нильк Р.Я. Омега-3 полиненасыщенные жирные кислоты в профилактике фибрилляции предсердий после хирургической реваскуляризации миокарда. Рациональная Фармакотерапия в Кардиологии. 2008;4(3):26-32

108. Zhang B, Zhen Y, Tao A, Bao Z, Zhang G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated meta-analysis of randomized controlled trials. Journal of Cardiology. 2014;63(1):53–9. DOI: 10.1016/j.jjcc.2013.06.014

109. Wang H, Chen J, Zhao L. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review. Journal of Interventional Cardiac Electrophysiology. 2018;51(2):105–15. DOI: 10.1007/s10840-018-0315-5

110. Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al. Рекомендации ESC по лечению пациентов с фибрилляцией предсердий, разработанные совместно с EACTS. Российский кардиологический журнал. 2017;22(7):7-86. DOI: 10.15829/1560-4071-2017-7-7-86

111. Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M et al. Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care. 2015;38(9):1665–72. DOI: 10.2337/dc15-0303

112. Бородашкина С.Ю., Подкаменный В.А., Протасов К.В. Сердечно-сосудистые осложнения и состояние углеводного обмена при коронарном шунтировании на «работающем сердце» в зависимости от режима сахароснижающей терапии у больных ишемической болезнью сердца и сахарном диабете 2 типа. Российский кардиологический журнал. 2016;21(2):19-24. DOI: 10.15829/1560- 4071-2016-2-19-24